Your Questions, Answered

We’ve assembled the most frequently asked questions about Eversense into one place. Got a question that you can’t find the answer to? Contact us.

Filter by topic:

The Eversense E3 CGM System is indicated for continually measuring glucose levels in adults (18 years or older) with diabetes for up to 180 days. The system is indicated for use to replace fingerstick blood glucose measurements for diabetes treatment decisions.

The system is intended to:

  • Provide real-time glucose readings.
  • Provide glucose trend information.
  • Provide alerts for the detection and prediction of episodes of low blood glucose (hypoglycemia) and high blood glucose (hyperglycemia).

The system is a prescription device. Historical data from the system can be interpreted to aid in providing therapy adjustments. These adjustments should be based on patterns and trends seen over time.
The system is intended for single patient use.

The Eversense® Charging Accessory Pack includes:

  • Charging Cradle (that is used to charge the Smart Transmitter)
  • Charging Cable
  • Wall Plug

Sensor: The sensor is considered medical waste and will be disposed of by your health care professional.
Transmitter: The transmitter contains a reusable battery and should be disposed of based on your local regulations.
Adhesive patch: The adhesive patch can be thrown away with normal household trash.

Your Eversense Inserter will explain and perform the simple and quick steps to insert the sensor. You will be fully awake during the approximately 5-minute insertion procedure. (The entire procedure, including preparation, usually takes about 15 minutes.)

It is important to choose a site (on the upper arm) that is comfortable for you to wear the sensor and smart transmitter for up to 180 days. It is recommended to have the sensor inserted toward the back of the upper arm. Placement in this area minimizes the chance of the sensor and smart transmitter being bumped by doorways, walls or other narrow passages. It is recommended to avoid areas with loose skin, scars, tattoos, nerves, or blood vessels that could be incised during the procedure. It is recommended to alternate arms for subsequent insertion sites.

Step 1: Site preparation – the insertion site will be cleaned, disinfected, then anesthetized using lidocaine.
Step 2: Incision – a small (less than 1 centimeter) incision will be made at the insertion site.
Step 3: Sensor insertion – a subcutaneous pocket will be created under the skin and the sensor will be inserted in this pocket.
Step 4: Site closure – the incision will be closed with Steri-Strips™. Sutures are not usually required.
Step 5: Sensor and smart transmitter linking – link the sensor and smart transmitter to begin the 24-hour Warm-Up Phase.

Note: After insertion, link the smart transmitter and the sensor and then allow the incision site to heal 24 hours before replacing the transmitter.

The sensor requires 24 hours to stabilize within the insertion site, this period is known as the Warm-up Phase. After the first 24 hours of sensor insertion, position and secure the smart transmitter over the sensor and ensure you have a connection. Then you can perform your Initialization Phase calibration of 4 fingerstick blood glucose tests to start getting glucose readings.

Homopolymer polymethylmethacrylate (PMMA), Hydroxyethylmethacrylate (HEMA) based Hydrogel, Platinum, Silicone, Dexamethasone Acetate, epoxy 301-2

You can find the Sensor Serial number in the Eversense® App that is connect to your Sensor and Transmitter.

  1. Tap Menu > Settings > System to display the SYSTEMS screen.
  2. On the SYSTEMS screen, you can tap each of the following:
  • Name: The serial number of your smart transmitter. You can also tap on the serial number displayed here and give your smart transmitter a custom name.
  • Linked Sensor: The serial number of the sensor currently linked with the smart transmitter. Tap this feature to access the ability to link or re-link a sensor.

Still have questions?

The Eversense team is dedicated and ready to provide the answers and support you need. Simply click the link below.

The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.

The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.

For important safety information, see bit.ly/eversensesafety

Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.


Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.

 

PP-SENS-E3-GBL-0060